Objective: To show the initial (first-year) experience with Ga-PSMA PET/CT at a clinic in Brazil.
Materials And Methods: Over a one-year period, 96 examinations with Ga-PSMA PET/CT (85 related to prostate cancer and 11 related to kidney cancer) were performed in 90 patients.
Results: In the prostate and kidney cancer patients alike, the main clinical indication for Ga-PSMA PET/CT was suspicion of recurrence during follow-up (in 65.